LPV Protocol, Dosing & Timeline | Peptide Dose Wizard

LPV Overview

Mechanism of Action

LPV (Larazotide Peptide Variant) is a synthetic peptide that acts as a tight junction regulator. It helps restore intestinal barrier integrity by modulating zonulin-mediated tight junction opening, reducing intestinal permeability ("leaky gut"). It has been studied in celiac disease and other conditions involving compromised gut barrier function.

Half-Life

Short-acting; rapidly metabolized in the GI tract. Administered multiple times daily.

Timing

15-30 minutes before meals

Injection Site

Subcutaneous injection - lower abdomen

Food

Administer before eating for optimal gut barrier support

Common Stacks

BPC-157 — Complementary gut healing
KPV — Anti-inflammatory gut support
Glutamine — Additional intestinal lining support

LPV Dosing Protocol

Standard Protocol

8-12 weeks

0.5-1 mg 3x/day

Take before meals. Acts locally in the gut.

Maintenance

As needed

0.5 mg 3x/day

May continue at lower dose for ongoing gut support.

LPV Expected Timeline

Week 1-2

Initial gut barrier stabilization; may notice reduced GI symptoms

Week 3-4

Improved intestinal permeability markers

Week 6-8

Significant improvement in gut barrier integrity and associated symptoms

Week 8-12

Full therapeutic benefit; sustained barrier function improvement

LPV Side Effects

Mild headache (uncommon)

GI discomfort during initial use

Nausea (rare)

LPV Research Studies

No studies referenced.

LPV FAQ

What is leaky gut?

Leaky gut (increased intestinal permeability) occurs when tight junctions in the intestinal lining become compromised, allowing larger molecules to pass through. LPV helps restore these tight junctions.